_version_ 1785090567283146752
author Vázquez, Celia Martinez
Charavia, Marta Callejas
Miranda, Daniel Gainza
Cilleruelo, Jose Maria Aspa
Guzman, López de Hontanar
Antonio, Rodríguez Barquero Pedro
Herreros, Paula Gili
Galina, Motornaya
Gómez, Maria Menor
Pérez, Carlota Portocarrero de Las Heras
Ramírez, Patricia García
Julio, Garcia Suarez
author_facet Vázquez, Celia Martinez
Charavia, Marta Callejas
Miranda, Daniel Gainza
Cilleruelo, Jose Maria Aspa
Guzman, López de Hontanar
Antonio, Rodríguez Barquero Pedro
Herreros, Paula Gili
Galina, Motornaya
Gómez, Maria Menor
Pérez, Carlota Portocarrero de Las Heras
Ramírez, Patricia García
Julio, Garcia Suarez
author_sort Vázquez, Celia Martinez
collection PubMed
description
format Online
Article
Text
id pubmed-10428843
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288432023-08-17 PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS Vázquez, Celia Martinez Charavia, Marta Callejas Miranda, Daniel Gainza Cilleruelo, Jose Maria Aspa Guzman, López de Hontanar Antonio, Rodríguez Barquero Pedro Herreros, Paula Gili Galina, Motornaya Gómez, Maria Menor Pérez, Carlota Portocarrero de Las Heras Ramírez, Patricia García Julio, Garcia Suarez Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428843/ http://dx.doi.org/10.1097/01.HS9.0000977380.42549.8a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Vázquez, Celia Martinez
Charavia, Marta Callejas
Miranda, Daniel Gainza
Cilleruelo, Jose Maria Aspa
Guzman, López de Hontanar
Antonio, Rodríguez Barquero Pedro
Herreros, Paula Gili
Galina, Motornaya
Gómez, Maria Menor
Pérez, Carlota Portocarrero de Las Heras
Ramírez, Patricia García
Julio, Garcia Suarez
PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS
title PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS
title_full PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS
title_fullStr PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS
title_full_unstemmed PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS
title_short PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS
title_sort pb2676: are novel therapeutic opportunities leading us to overtreat patients?: a review of end-of-life situation in haematological patients
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428843/
http://dx.doi.org/10.1097/01.HS9.0000977380.42549.8a
work_keys_str_mv AT vazquezceliamartinez pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT charaviamartacallejas pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT mirandadanielgainza pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT cilleruelojosemariaaspa pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT guzmanlopezdehontanar pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT antoniorodriguezbarqueropedro pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT herrerospaulagili pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT galinamotornaya pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT gomezmariamenor pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT perezcarlotaportocarrerodelasheras pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT ramirezpatriciagarcia pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients
AT juliogarciasuarez pb2676arenoveltherapeuticopportunitiesleadingustoovertreatpatientsareviewofendoflifesituationinhaematologicalpatients